Patents by Inventor Mihir Metkar

Mihir Metkar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230355743
    Abstract: The disclosure provides coronavirus ribonucleic acid (RNA) vaccines as well as methods of using the vaccines and compositions comprising the vaccines.
    Type: Application
    Filed: September 24, 2021
    Publication date: November 9, 2023
    Applicant: ModernaTX, Inc.
    Inventors: Guillaume Stewart-Jones, Mihir Metkar, Vladimir Presnyak
  • Publication number: 20230346914
    Abstract: The disclosure relates to coronavirus ribonucleic acid (RNA) vaccines as well as methods of using the vaccines and compositions comprising the vaccines. The RNA vaccines encode domains and subunits of coronavirus.
    Type: Application
    Filed: February 6, 2021
    Publication date: November 2, 2023
    Applicant: ModernaTX, Inc.
    Inventors: Guillaume Stewart-Jones, Andrea Carfi, Sayda Mahgoub Elbashir, Mihir Metkar
  • Publication number: 20230108894
    Abstract: The disclosure relates to coronavirus ribonucleic acid (RNA) vaccines as well as methods of using the vaccines and compositions comprising the vaccines.
    Type: Application
    Filed: January 26, 2021
    Publication date: April 6, 2023
    Applicant: Moderna TX, Inc
    Inventors: Guillaume Stewart-Jones, Elisabeth Narayanan, Hamilton Bennett, Andrea Carfi, Mihir Metkar, Vladimir Presnyak
  • Publication number: 20220323572
    Abstract: The disclosure relates to coronavirus ribonucleic acid (RNA) vaccines as well as methods of using the vaccines and compositions comprising the vaccines.
    Type: Application
    Filed: November 3, 2021
    Publication date: October 13, 2022
    Applicant: ModernaTX, Inc.
    Inventors: Mihir Metkar, Valdimir Presnyak
  • Publication number: 20210228707
    Abstract: The disclosure relates to coronavirus ribonucleic acid (RNA) vaccines as well as methods of using the vaccines and compositions comprising the vaccines.
    Type: Application
    Filed: August 21, 2020
    Publication date: July 29, 2021
    Applicant: ModernaTX, Inc.
    Inventors: Mihir Metkar, Vladimir Presnyak, Guillaume Stewart-Jones